FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089347876> ?p ?o ?g. }

• W3089347876 endingPage "3387" @default.
• W3089347876 startingPage "3383" @default.
• W3089347876 abstract "Thymic carcinoma is a rare and highly aggressive mediastinal tumor. Most patients are diagnosed at surgically unresectable stages. Current prospective and retrospective studies have indicated that platinum and anthracycline‐based chemotherapy are the first choice drugs of first‐line therapy for advanced thymic carcinoma. However, there is no optimal treatment after progression for patients who have undergone first‐line and subsequent chemotherapy. Anlotinib, a novel small molecule tyrosine kinase multitarget inhibitor, was approved by the China Food and Drug Administration as a third‐line treatment for advanced non‐small cell lung cancer (NSCLC) in May 2018. Herein we report a case of an advanced thymic squamous cell carcinoma patient harboring EGFR exon 20 insertion who had previously received multiline therapy, including chemotherapy, radiotherapy as well as antiangiogenic therapy. Also as an angiogenesis inhibitor, anotinib had controlled his mediastinal mass after failure of the apatinib treatment. To date, over 23 months of progression‐free survival (PFS) and six years of overall survival (OS) have been achieved. Compared with apatinib, the adverse reactions have been mild and tolerable and the patient's quality of life has improved. To our knowledge, this is the first report where anlotinib has been effective in controlling the progression of thymic carcinoma. In the multiline treatment of advanced thymic carcinoma, anlotinib appears to show great potential when utilized as a salvage treatment." @default.
• W3089347876 created "2020-10-08" @default.
• W3089347876 creator A5027335182 @default.
• W3089347876 creator A5029726983 @default.
• W3089347876 creator A5036950610 @default.
• W3089347876 creator A5039383725 @default.
• W3089347876 creator A5048322569 @default.
• W3089347876 creator A5050827327 @default.
• W3089347876 creator A5052788634 @default.
• W3089347876 creator A5070186527 @default.
• W3089347876 creator A5086360069 @default.
• W3089347876 date "2020-09-30" @default.
• W3089347876 modified "2023-09-30" @default.
• W3089347876 title "Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review" @default.
• W3089347876 cites W1579297325 @default.
• W3089347876 cites W1899263864 @default.
• W3089347876 cites W1966825185 @default.
• W3089347876 cites W1992112921 @default.
• W3089347876 cites W2029883618 @default.
• W3089347876 cites W2096843927 @default.
• W3089347876 cites W2097731330 @default.
• W3089347876 cites W2139863684 @default.
• W3089347876 cites W2168558240 @default.
• W3089347876 cites W2255518001 @default.
• W3089347876 cites W2346237485 @default.
• W3089347876 cites W2791667474 @default.
• W3089347876 cites W2793605704 @default.
• W3089347876 cites W2801347531 @default.
• W3089347876 cites W2805389764 @default.
• W3089347876 cites W2889570909 @default.
• W3089347876 cites W2905647095 @default.
• W3089347876 cites W2969424055 @default.
• W3089347876 cites W2971012640 @default.
• W3089347876 cites W3034160707 @default.
• W3089347876 doi "https://doi.org/10.1111/1759-7714.13658" @default.
• W3089347876 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7606018" @default.
• W3089347876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32997432" @default.
• W3089347876 hasPublicationYear "2020" @default.
• W3089347876 type Work @default.
• W3089347876 sameAs 3089347876 @default.
• W3089347876 citedByCount "7" @default.
• W3089347876 countsByYear W30893478762021 @default.
• W3089347876 countsByYear W30893478762022 @default.
• W3089347876 countsByYear W30893478762023 @default.
• W3089347876 crossrefType "journal-article" @default.
• W3089347876 hasAuthorship W3089347876A5027335182 @default.
• W3089347876 hasAuthorship W3089347876A5029726983 @default.
• W3089347876 hasAuthorship W3089347876A5036950610 @default.
• W3089347876 hasAuthorship W3089347876A5039383725 @default.
• W3089347876 hasAuthorship W3089347876A5048322569 @default.
• W3089347876 hasAuthorship W3089347876A5050827327 @default.
• W3089347876 hasAuthorship W3089347876A5052788634 @default.
• W3089347876 hasAuthorship W3089347876A5070186527 @default.
• W3089347876 hasAuthorship W3089347876A5086360069 @default.
• W3089347876 hasBestOaLocation W30893478761 @default.
• W3089347876 hasConcept C121608353 @default.
• W3089347876 hasConcept C126322002 @default.
• W3089347876 hasConcept C143998085 @default.
• W3089347876 hasConcept C197934379 @default.
• W3089347876 hasConcept C2776056115 @default.
• W3089347876 hasConcept C2776349617 @default.
• W3089347876 hasConcept C2776694085 @default.
• W3089347876 hasConcept C2777546739 @default.
• W3089347876 hasConcept C2778820342 @default.
• W3089347876 hasConcept C2780668389 @default.
• W3089347876 hasConcept C2781230642 @default.
• W3089347876 hasConcept C71924100 @default.
• W3089347876 hasConceptScore W3089347876C121608353 @default.
• W3089347876 hasConceptScore W3089347876C126322002 @default.
• W3089347876 hasConceptScore W3089347876C143998085 @default.
• W3089347876 hasConceptScore W3089347876C197934379 @default.
• W3089347876 hasConceptScore W3089347876C2776056115 @default.
• W3089347876 hasConceptScore W3089347876C2776349617 @default.
• W3089347876 hasConceptScore W3089347876C2776694085 @default.
• W3089347876 hasConceptScore W3089347876C2777546739 @default.
• W3089347876 hasConceptScore W3089347876C2778820342 @default.
• W3089347876 hasConceptScore W3089347876C2780668389 @default.
• W3089347876 hasConceptScore W3089347876C2781230642 @default.
• W3089347876 hasConceptScore W3089347876C71924100 @default.
• W3089347876 hasIssue "11" @default.
• W3089347876 hasLocation W30893478761 @default.
• W3089347876 hasLocation W30893478762 @default.
• W3089347876 hasOpenAccess W3089347876 @default.
• W3089347876 hasPrimaryLocation W30893478761 @default.
• W3089347876 hasRelatedWork W2283064216 @default.
• W3089347876 hasRelatedWork W2766366470 @default.
• W3089347876 hasRelatedWork W2772987978 @default.
• W3089347876 hasRelatedWork W2982295426 @default.
• W3089347876 hasRelatedWork W3014655733 @default.
• W3089347876 hasRelatedWork W3089347876 @default.
• W3089347876 hasRelatedWork W3094177542 @default.
• W3089347876 hasRelatedWork W3133884904 @default.
• W3089347876 hasRelatedWork W4226485381 @default.
• W3089347876 hasRelatedWork W2560317214 @default.
• W3089347876 hasVolume "11" @default.
• W3089347876 isParatext "false" @default.
• W3089347876 isRetracted "false" @default.
• W3089347876 magId "3089347876" @default.

• next